KURA FY 2009 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$783M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$19,158

Operating Income

-$38,316

Net Income

-$19,996

EPS (Diluted)

$-0.00

Cash Flow

Operating Cash Flow

-$21,366

Free Cash Flow

-$21,366

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$13,017

Total Liabilities

$31,613

Stockholders' Equity

-$18,596

Cash & Equivalents

$11,142

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$19,158	$0	—
Operating Income	-$38,316	-$33,623	-14.0%
Net Income	-$19,996	-$33,623	+40.5%